Lisata Therapeutics (LSTA)

• Market cap: $19.5M
• 1 day: 8.65%
• 5 days: 15.90%
• 1 month: -5.04%
• 3 months: -39.08%
• 6 months: -23.13%
• Year to date: -36.69%
• 1 year: -18.71%
• 5 years: -2.16%
• 10 years: -92.01%
• Sector: Healthcare
• Industry: Biotechnology

About: Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Employees: 26

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

5% more funds holding

Funds holding: 20 [Q3] → 21 (+1) [Q4]

2% more capital invested

Capital invested by funds: $2.3M [Q3] → $2.33M (+$38.7K) [Q4]

0.15% more ownership

Funds ownership: 9.21% [Q3] → 9.35% (+0.15%) [Q4]